Masayuki Sho Selected Research

Pancreaticoduodenectomy

8/2023	Pancreatic ductal adenocarcinoma arising from the pancreatic parenchyma compressed by a huge pancreatic lipoma: a case report.
4/2022	Nonalcoholic fatty liver disease developed after pancreatoduodenectomy for solid pseudopapillary neoplasm in a 10-year-old girl: a case report.
1/2022	Surgical results of non-ampullary duodenal cancer: a nationwide survey in Japan.
3/2021	Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.
1/2021	Left-sided Portal Hypertension After Pancreaticoduodenectomy With Resection of the Portal Vein/Superior Mesenteric Vein Confluence in Patients With Pancreatic Cancer: A Project Study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.
12/2020	New insight into the association between bile infection and clinically relevant pancreatic fistula in patients undergoing pancreatoduodenectomy.
7/2020	Propensity score-matched analysis of internal stent vs external stent for pancreatojejunostomy during pancreaticoduodenectomy: Japanese-Korean cooperative project.
1/2020	No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After Pancreaticoduodenectomy.
8/2019	The efficacy of polyglycolic acid felt reinforcement in preventing postoperative pancreatic fistula after pancreaticojejunostomy in patients with main pancreatic duct less than 3 mm in diameter and soft pancreas undergoing pancreatoduodenectomy (PLANET-PJ trial): study protocol for a multicentre randomized phase III trial in Japan and Korea.
2/2019	Risk Factors for Late-Onset Gastrointestinal Hemorrhage After Pancreatoduodenectomy for Pancreatic Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masayuki Sho Research Topics

Disease

64	Neoplasms (Cancer) 12/2023 - 04/2003
46	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 04/2003
31	Neoplasm Metastasis (Metastasis) 09/2023 - 11/2009
26	Adenocarcinoma 12/2023 - 11/2014
12	Stomach Neoplasms (Stomach Cancer) 02/2024 - 07/2010
10	Pancreatic Fistula (Pancreatic Fistulas) 01/2022 - 02/2013
9	Lymphatic Metastasis 01/2022 - 06/2015
8	Esophageal Neoplasms (Esophageal Cancer) 04/2024 - 04/2005
7	Inflammation (Inflammations) 10/2022 - 08/2003
6	Hemorrhage 10/2023 - 12/2017
6	Reperfusion Injury 11/2019 - 05/2005
5	Adenoma (Adenomas) 01/2022 - 03/2015
5	Disease Progression 01/2022 - 04/2010
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 11/2010
4	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2015
3	Rectal Neoplasms (Rectal Cancer) 11/2023 - 01/2018
3	Surgical Wound Infection 01/2023 - 04/2016
3	Polyps 10/2022 - 03/2015
3	Esophageal Squamous Cell Carcinoma 05/2022 - 03/2014
3	Non-alcoholic Fatty Liver Disease 04/2022 - 03/2014
3	Pneumonia (Pneumonitis) 01/2022 - 12/2005
3	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 01/2018
2	Breast Neoplasms (Breast Cancer) 06/2024 - 04/2021
2	Hypoxia (Hypoxemia) 02/2024 - 04/2023
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2023 - 01/2023
2	Sarcopenia 11/2023 - 12/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2023 - 01/2011
2	Neoplasms, Cystic, Mucinous, and Serous 01/2023 - 07/2019
2	Renal Insufficiency (Renal Failure) 01/2021 - 11/2015
2	Body Weight (Weight, Body) 01/2021 - 11/2018
2	Carcinoma (Carcinomatosis) 10/2020 - 09/2015
2	Residual Neoplasm 02/2019 - 11/2010
2	Fatigue 01/2017 - 01/2016

Drug/Important Bio-Agent (IBA)

18	Gemcitabine FDA Link 12/2023 - 04/2007
10	Biomarkers (Surrogate Marker)IBA 03/2023 - 06/2016
9	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 01/2013
7	AntigensIBA 12/2023 - 04/2010
7	Fluorouracil (Carac)FDA LinkGeneric 09/2020 - 11/2009
6	CarbohydratesIBA 12/2023 - 02/2019
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 08/2003
6	Proteins (Proteins, Gene)FDA Link 05/2020 - 04/2003
5	Tumor Biomarkers (Tumor Markers)IBA 09/2023 - 01/2017
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 01/2013
5	Irinotecan (Camptosar)FDA LinkGeneric 10/2020 - 01/2016
5	Small Interfering RNA (siRNA)IBA 09/2020 - 04/2010
4	Member 14 Tumor Necrosis Factor ReceptorsIBA 11/2019 - 03/2014
3	EnzymesIBA 04/2022 - 03/2014
3	CytokinesIBA 01/2020 - 08/2003
3	degradable starch microspheresIBA 03/2017 - 01/2013
3	PowdersIBA 03/2017 - 01/2013
3	LigandsIBA 02/2009 - 04/2005
2	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2024 - 04/2023
2	Therapeutic UsesIBA 10/2023 - 01/2011
2	C-Reactive ProteinIBA 01/2023 - 11/2018
2	MicroRNAs (MicroRNA)IBA 12/2022 - 01/2020
2	InterferonsIBA 10/2022 - 05/2013
2	Hemoglobins (Hemoglobin)IBA 09/2022 - 08/2020
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2022 - 01/2013
2	Alanine Transaminase (SGPT)IBA 04/2022 - 01/2013
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 04/2003
2	Carcinoembryonic AntigenIBA 09/2021 - 11/2018
2	Serum AlbuminIBA 01/2021 - 11/2018
2	Leucovorin (Folinic Acid)FDA Link 10/2020 - 01/2013
2	tegafur-gimeracil-oteracilIBA 10/2020 - 12/2017
2	Docetaxel (Taxotere)FDA Link 09/2020 - 10/2017
2	Claudin-4IBA 11/2019 - 03/2019
2	von Willebrand FactorIBA 11/2019 - 01/2018
2	folfirinoxIBA 11/2019 - 01/2019
2	N-acetyltalosaminuronic acid (NAT)IBA 06/2019 - 07/2015
2	Fibrinogen (Factor I)FDA Link 04/2019 - 01/2017
2	Pancrelipase (Creon)FDA Link 03/2016 - 03/2014
2	Monoclonal AntibodiesIBA 01/2011 - 04/2007

Therapy/Procedure

34	Drug Therapy (Chemotherapy) 06/2024 - 04/2009
25	Neoadjuvant Therapy 01/2024 - 11/2011
21	Pancreaticoduodenectomy 08/2023 - 11/2009
20	Therapeutics 10/2023 - 12/2005
16	Pancreatectomy 12/2023 - 04/2012
10	Adjuvant Chemotherapy 06/2024 - 11/2009
7	Operative Surgical Procedures 06/2024 - 03/2014
6	Length of Stay 06/2024 - 02/2013
6	Esophagectomy 04/2024 - 11/2018
6	Hepatectomy 12/2023 - 11/2019
6	Gastrectomy 09/2022 - 07/2010
4	Splenectomy 02/2023 - 03/2013
4	Combination Drug Therapy (Combination Chemotherapy) 09/2020 - 11/2009
3	Stents 01/2023 - 02/2019
3	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2023 - 06/2018
3	Blood Transfusion (Blood Transfusions) 01/2021 - 01/2016
3	Chemoradiotherapy 01/2021 - 11/2011
3	Pancreaticojejunostomy 07/2020 - 01/2016
3	Radiotherapy 06/2019 - 11/2010
3	Ligation 02/2019 - 08/2003
3	Operative Time 01/2018 - 01/2017
3	Combined Modality Therapy 11/2016 - 11/2010
2	Immunotherapy 05/2022 - 04/2005
2	Sutures (Suture) 05/2022 - 04/2021
2	Colectomy 01/2022 - 11/2010
2	Microspheres (Microsphere) 08/2019 - 03/2017
2	Catheters 06/2016 - 11/2011
2	Vascular Access Devices (Arterial Line) 06/2016 - 06/2012